close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Patient Dosing

Recent news which mentions Patient Dosing

Lyra's Mid-Stage Chronic Rhinosinusitis Candidate Study Progressed, Shares Fall
Tickers LYRA
Tags LYRA Benzinga General
From Benzinga
Emergent Shares Decline Following Commencement Of Initial-Stage Lassa Virus Vaccine Candidate Study
Tickers EBS
Tags Benzinga General Small Cap
From Benzinga
Werewolf Shares Climb As Initial-Stage Solid Tumors Study Kicks-off
Tickers HOWL
Tags Patient Dosing General Benzinga
From Benzinga
Geron Commences Initial-Stage Rare Blood Cancer Combination Study
Tickers GERN
Tags Patient Dosing Penny Stocks Small Cap
From Benzinga
Kronos Bio Shares Fall After Initial-Stage Blood Cancer Study Takes-off
Tickers KRON
Tags Patient Dosing Penny Stocks General
From Benzinga
Graphite Bio Shares Soar As Initial-Stage Blood Cell Disorder Study Launched
Tickers GRPH
Tags Patient Dosing Benzinga General
From Benzinga
Passage Bio Commences Initial-Stage Brain Disorder Study
Tickers PASG
Tags Market News Health Care Biotech
From Benzinga
Capricor Initiates Late-Stage Neuropsychiatric Disorder Study
Tickers CAPR
Tags Penny Stocks Benzinga General
From Benzinga
Impel Commences Mid-Stage Autism Spectrum Disorder Study
Tickers IMPL
Tags Biotech IMPL Market News
From Benzinga
Pulmatrix Commences Initial-Stage Acute Migraine Study
Tickers PULM
Tags General Benzinga Penny Stocks
From Benzinga
Synlogic Initiates Initial-Stage Homocystinuria Study
Tickers SYBX
Tags Health Care Market News Biotech
From Benzinga
Immunocore Commences Initial-Stage HIV Study
Tickers IMCR
Tags Biotech IMCR Hedge Funds
From Benzinga
Calithera Commences Mid-Stage Study Of DLBCL Candidate
Tickers CALA
Tags Health Care CALA Market News
From Benzinga
Biomea Fusion Commences Initial-Stage Study For Plasma Cell Cancer Setting
Tickers BMEA
Tags Biotech Health Care Market News
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today